Sponsor pipeline

Aktiia SA clinical trial pipeline

8 active trials 7 recruiting 1 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Not charted: 8 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Not applicable
NCT07507903	OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical…	Hypertension	Recruiting	2026-09-14
NCT07523269	WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure…	Hypertension (HTN)	Recruiting	2026-04-13
NCT04027777	Aktiia OPBM Single-center Prospective Observational Study Against Double Auscultation	Blood Pressure	Recruiting	2026-04-06
NCT05780710	OBPM_Meds2023: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical…	Hypertension	Recruiting	2026-02-05
NCT06698536	OBPM_COYOTE2024 Physiological Data Recording With the Calibration-free Optical Aktiia G2C…	Hypertension	Recruiting	2025-05-14
NCT06368206	Recording of Physiological Data Via an Optical Sensor At the Fingertip Alongside with…	Hypertension	Recruiting	2024-12-17
Not specified
NCT06670677	Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early…	Hypertension	Recruiting	2025-05-14
NCT07099716	OBPM_HARMONY: Physiological Data Recording Over 24 Hours Using the Continual Optical Hilo…	Hypertension	Not Yet Recruiting	2025-09-12

Get alerts when Aktiia SA's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.